INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 143 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2016. The put-call ratio across all filers is 1.43 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $47,000 | +2250.0% | 10,157 | +5360.8% | 0.00% | – |
| Q3 2018 | $2,000 | -98.5% | 186 | -99.0% | 0.00% | -100.0% |
| Q2 2018 | $131,000 | +309.4% | 18,064 | +404.9% | 0.01% | +133.3% |
| Q3 2017 | $32,000 | +433.3% | 3,578 | +416.3% | 0.00% | +200.0% |
| Q4 2016 | $6,000 | +500.0% | 693 | +593.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 100 | +112.8% | 0.00% | – |
| Q2 2016 | $1,000 | -87.5% | 47 | -91.1% | 0.00% | -100.0% |
| Q1 2016 | $8,000 | -33.3% | 526 | +20.6% | 0.00% | -50.0% |
| Q4 2015 | $12,000 | +300.0% | 436 | +323.3% | 0.00% | – |
| Q3 2015 | $3,000 | -95.7% | 103 | -94.8% | 0.00% | -100.0% |
| Q2 2015 | $70,000 | +34.6% | 1,963 | +117.6% | 0.01% | 0.0% |
| Q1 2015 | $52,000 | +550.0% | 902 | +351.0% | 0.01% | +500.0% |
| Q4 2014 | $8,000 | -78.4% | 200 | -78.9% | 0.00% | -75.0% |
| Q3 2014 | $37,000 | +270.0% | 946 | +204.2% | 0.00% | +300.0% |
| Q2 2014 | $10,000 | -79.6% | 311 | -73.5% | 0.00% | -83.3% |
| Q1 2014 | $49,000 | +1125.0% | 1,173 | +1073.0% | 0.01% | +500.0% |
| Q4 2013 | $4,000 | -85.2% | 100 | -86.9% | 0.00% | -66.7% |
| Q3 2013 | $27,000 | -35.7% | 761 | -74.6% | 0.00% | 0.0% |
| Q2 2013 | $42,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |